fda pulling semaglutide is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified US judge upholds FDA's removal

Body mass index had no clinically meaningful effect on the pharmacokinetics of sitagliptin based on a composite analysis of Phase I pharmacokinetic data and on a population pharmacokinetic analysis of Phase I and Phase II data

Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial

If you experience any of the following, its a sign to stop treatment and reach out to your healthcare provider: Even if the symptom seems minor, its always better to be cautious

When medication is removed suddenly, these signals stop almost immediately, and hunger hormones like ghrelin rebound quickly

Datta, S., Cano, M., Ebrahimi, K., Wang, L